Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | UBE2N | P61088 | 1/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10936368 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL27679537 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL11486624 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL28133352 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL9637168 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL2197335 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL23038706 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL10941210 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL9637167 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 | |
| SCHEMBL22444497 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNAOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111808011-B | High penetration composition and its application | 泰飞尔生物医药(苏州)有限公司 | 2024-02-27 | — | — | CN | disclosed |
| US-8485657-B2 | Sublimation printing processes and fabric pretreatment compositions for ink jet printing onto arbitrary fabrics | ADVANCED CHEMICAL SOLUTIONS, LLC (US) | 2013-07-16 | — | — | US | disclosed |
| US-20110169901-A1 | Sublimation Printing Processes and Fabric Pretreatment Compositions for Ink Jet Printing onto Arbitrary Fabrics | ADVANCED CHEMICAL SOLUTIONS, LLC (US) | 2011-07-14 | — | — | US | disclosed |
| US-20090220443-A1 | COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2009-09-03 | — | — | US | disclosed |
| EP-1188856-B1 | Ink-jet printing method and printed goods | SEIREN CO LTD (JP) | 2005-11-16 | — | — | EP | disclosed |
| US-6623532-B2 | Cellulose and synthetic fibers is treated with an acidic aqueous dispersion containing cellulose reactive compound, water soluble polymer, non-water soluble inactive organic compound, drying, ink-jet printing with reactive and disperse | SEIREN CO., LTD. (JP) | 2003-09-23 | — | — | US | disclosed |
| EP-1188856-A1 | Ink-jet printing method and printed goods | SEIREN CO., LTD. (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-20020025379-A1 | Ink-jet printing method and printed goods | SEIREN CO., LTD. | 2002-02-28 | — | — | US | disclosed |
| EP-0746311-B1 | MEDICINAL PATCHES FOR PERCUTANEOUS ADMINISTRATION | PACIFIC CORP (KR) | 2001-07-11 | — | — | EP | disclosed |
| EP-0746311-A1 | MEDICINAL PATCHES FOR PERCUTANEOUS ADMINISTRATION | PACIFIC CORPORATION (KR) | 1996-12-11 | — | — | EP | disclosed |
| WO-1996019976-A1 | MEDICINAL PATCHES FOR PERCUTANEOUS ADMINISTRATION | PACIFIC CORPORATION (KR) | 1996-07-04 | — | — | WO | disclosed |
| US-5505956-A | TRANSDERMAL SKIN PATCH | PACIFIC CHEMICAL CO., LTD. (KR) | 1996-04-09 | — | — | US | disclosed |
| US-5470563-A | Polyethersiloxane | SHISEIDO COMPANY LTD. (JP) | 1995-11-28 | — | — | US | disclosed |
| EP-0266921-A2 | Skin irritation alleviation agent and composition thereof | SHISEIDO COMPANY LIMITED (JP) | 1988-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220443-A1 | COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | MGLL, SQLE, PHOSPHO1 | GPR84 472/4885SPHK1 272/4885FFAR1 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.